The scientists who treated Baby KJ say the FDA's strict standards will make it much harder to create bespoke gene editing for ...
UF scientist develops safer gene therapy restoring vision in children with rare inherited eye diseases; pivotal trials begin ...
A growing body of evidence suggests that a single gene, APOE, may play a far more dominant role in Alzheimer’s disease than ...
Though the therapy, Kresladi, isn’t seen as a big seller, its clearance is a step forward for a company that’s lost most of ...
With an end-of-week green light from the FDA, Rocket Pharmaceuticals has officially broken into commercial orbit. | Rocket ...
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) is one of the best multibagger penny stocks to invest in. On March 25, Cantor ...
Why are some people unable to hear from birth, even though their inner ear appears intact? One possible cause lies in the ...
Gene drives—a genetic engineering approach that quickly spreads specific genetic changes throughout a population, whether to ...
For the millions of people who carry the gene APOE4, the strongest known genetic risk factor for Alzheimer's disease, their ...
Upon approval, Rocket has been awarded a priority review voucher, which currently fetch around $200m on the secondary market.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results